<?xml version="1.0" encoding="UTF-8"?>
<ref id="B126">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kim</surname>
    <given-names>Y. J.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y. T.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>M. C.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>Y. N.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>K. H.</given-names>
   </name>
   <name>
    <surname>Ko</surname>
    <given-names>E. J.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2017</year>). 
  <article-title>Cross-protective efficacy of influenza virus M2e containing virus-like particles is superior to hemagglutinin vaccines and variable depending on the genetic backgrounds of mice</article-title>. 
  <source>Front. Immunol.</source>
  <volume>8</volume>:
  <fpage>1730</fpage>. 
  <pub-id pub-id-type="doi">10.3389/fimmu.2017.01730</pub-id>
  <?supplied-pmid 29276514?>
  <pub-id pub-id-type="pmid">29276514</pub-id>
 </mixed-citation>
</ref>
